Hongyu Zhou

Molecular Medicine · with Beevers · 2011

A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Hongyu Zhou trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Bharat B. Aggarwal
  2. Ricky A. Sharma
  3. Dos D. Sarbassov
  4. M. Hayden
  5. A. Cheng
  6. D. Fingar
  7. Y. Yarden
  8. N. Hay
  9. A. Strimpakos
  10. M. Scaltriti

Who trusts Hongyu Zhou overall

  1. P. Basnet

Papers from Hongyu Zhou's perspective

Ordered by how strongly the researchers Hongyu Zhou trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR Complex (Science)
  2. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. (Current Biology)
  3. Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. (Cell)
  4. mTOR·RICTOR Is the Ser473 Kinase for Akt/Protein Kinase B in 3T3-L1 Adipocytes* (Journal of Biological Chemistry)
  5. GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR. (Molecules and Cells)
  6. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive (Nature Cell Biology)
  7. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. (Anticancer Research)
  8. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. (TIPS - Trends in Pharmacological Sciences)
  9. Curcumin (diferuloylmethane) down-regulates the constitutive activation of nuclear factor–κB and IκBα kinase in human multiple myeloma cells, leading to suppression of proliferation and induction of…
  10. Upstream and downstream of mTOR. (Genes & Development)

Their papers